Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma – a pilot prospective study

PURPOSE: The clinical utility of plasma cell-free DNA (cfDNA) has not been assessed prospectively in patients with glioblastoma (GBM). We aimed to determine the prognostic impact of plasma cfDNA in GBM, as well as its role as a surrogate of tumor burden and substrate for next-generation sequencing (...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Clin Cancer Res
Główni autorzy: Bagley, Stephen J., Nabavizadeh, S. Ali, Mays, Jazmine J., Till, Jacob E., Ware, Jeffrey B., Levy, Scott, Sarchiapone, Whitney, Hussain, Jasmin, Prior, Timothy, Guiry, Samantha, Christensen, Theresa, Yee, Stephanie S., Nasrallah, MacLean P., Morrissette, Jennifer J.D., Binder, Zev A., O’Rourke, Donald M., Cucchiara, Andrew J., Brem, Steven, Desai, Arati S., Carpenter, Erica L.
Format: Artigo
Język:Inglês
Wydane: 2019
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6980766/
https://ncbi.nlm.nih.gov/pubmed/31666247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2533
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy